Journals / Turkish Journal of Pharmaceutical Sciences / 2014 / Cilt: 11 - Sayı: 2

Studies of Lipid Profile, Liver and Kidney Function Parameters of Female Rat Plasma After the Administration of “Khadiraristha”

Khadiraristha Uygulaması Sonrasında Dişi Sıçan Plazmasında Lipid Profili, Karaciğer ve Böbrek Fonksiyonları Parametreleri Üzerinde Çalışmalar

Pages
145–152
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Our results suggest that KDR might have a noble role in those patients who have hypertriglyceridemia and hypercholesterolemia as it improves Triglyceride and HDL levels

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study, Khadiraristha (KDR), a traditional Ayurvedic preparation used in dermatological disorder has been investigated for its biochemical effects and in some extent justify the pharmacological uses under the stated circumstances.
📊
Key Findings & Data:Khadiraristha was administered orally to female albino rat for 46 days.
💡
Conclusion & Impact:Our results suggest that KDR might have a noble role in those patients who have hypertriglyceridemia and hypercholesterolemia as it improves Triglyceride and HDL levels
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In this study, Khadiraristha (KDR), a traditional Ayurvedic preparation used in dermatological disorder has been investigated for its biochemical effects and in some extent justify the pharmacological uses under the stated circumstances. Khadiraristha was administered orally to female albino rat for 46 days. After the treatment period animals were fasted for 18 hours. Biochemical parameters including; Total protein, Serum albumin, Blood Urea Nitrogen, Bilirubin, Liver enzymes (sGPT, sGOT, ALT) were determined in the plasma. KDR significantly increased (p<0.05) Total protein, Seruma Albumin, Total cholesterol, HDL, Liver enzymes (sGPT, sGOT, ALT) and Urea levels than their corresponding controls while decreased (p<0.001) Triglyceride and Creatinine levels. Hence, KDR may cause liver toxicity (due to the increased liver enzymes) and kidney dysfunction (due to the increased level of Creatinine). Our results suggest that KDR might have a noble role in those patients who have hypertriglyceridemia and hypercholesterolemia as it improves Triglyceride and HDL levels

Özet

Bu çalışmada, geleneksel ayürvedik bir preparat olan Khadiraristha'nın (KDR) dermatolojik bozukluklardaki kullanımı, biyokimyasal etkileri ve bazı durumlarda belirtilen koşullar altındaki farmakolojik kullanımları araştırılmıştır. KDR, dişi albino sıçanlara 46 gün oral yolla uygulanmıştır. Uygulama periyodundan sonar hayvanlar 18 saat aç bırakılmışlardır. Sonrasında plazmada, total protein, serum albumin, kan üre azot, bilirubin ve karaciğer enzimleri (sGPT, sGOT, ALT) tayinleri yapılmıştır. KDR uygulaması total protein, serum albumin, total kolesterol, HDL, karaciğer enzimleri (sGPT, sGOT, ALT), ve üreyi kontrollere göre istatistiksel olarak anlamlı bir seviyede arttırmış (p<0.05) buna karşılık trigliserid ve kreatinin seviyelerini ise istatistiksel olarak anlamlı bir seviyede azaltmıştır (p<0.001). Bu sonuçlara göre KDR karaciğer toksisitesine (artan karaciğer enzimleri nedeniyle) ve böbreklerde fonksiyon bozukluğuna (kreatinine seviyesindeki düşme nedeniyle) sebep olduğu düşünülebilir. Bizim sonuçlarımız, KDR'nin trigliserid ve HDL seviyelerini düzeltebilmesi nedeniyle hipertrigliseridemi ve hiperkolesterolemili hastalarda faydalı bir rolü olabileceğini göstermektedir

🔖

Cite This Article

AL-AMIN, M. M., REZA, H. M., ISLAM, M. N., UDDIN, M. M. N., CHOUDHURI, S. K. (2014). Studies of Lipid Profile, Liver and Kidney Function Parameters of Female Rat Plasma After the Administration of “Khadiraristha”. Turkish Journal of Pharmaceutical Sciences, Cilt: 11 - Sayı: 2, 145–152. https://ajindex.com/articles/403999

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Cragg GM, Newman DJ, Natural product drug discovery in the next millennium, Pharm Biol 39, S1, 8-17, 2001
  2. Chopra A, Doiphode V, Ayurvedic medicine. Core concept, therapeutic principles and current relevance, Med Clin North Am 86(1), 75-89, 2002
  3. Thatte U, Bhalerao S, Pharmacovigilance of ayurvedic medicines in India, Indian J Pharmacol 40(7), 10-12, 2008
  4. Gogtay NJ, Bhatt HA, Dalvi SS, Kshirsagar NA, The use and safety of non-allopathic Indian medicines, Drug Saf 25(14), 1005-19, 2002
  5. Thatte UM, Rege NN, Phatak SD, Dahanukar SA, The flip side of Ayurveda, J Postgr Med 39(4), 179-82, 182a-182b, 1993
  6. Dhruve KD, Prajapati PK, A Clinical Trial of Khadiraristha In The Management Of Kustha, International Journal of Research in Ayurveda & Pharmacy 2(4), 1044, 2011
  7. Anonymous, Bangladesh National Formulary of Ayurvedic Medicine Dhaka, 1992
  8. Abraham E, Ayurvedic medicinal plants, accessed on 26 Feb, 2013,
  9. Logayurveda, Ayurveda Formulation, accessed on 26 Feb, 2013, www.logayurveda.com
  10. Pharmaveda, Ayurvedic Drugs, accessed on 26 Feb, 2013,
  11. Sharma PV, Essentials of Ayurveda, 58-59, India: Motilal Banarsidass Publishers Pvt. Ltd., 1998
  12. Arogyadham HC, Ayurvedic Yog - Khadirarista, accessed on 28 Feb, 2013, http://www.ayurvedaconsultants.com. 13.Ismail S, Asad M, Immunomodulatory activity of Acacia catechu, Indian J Physiol Pharmacol 53(1), 25-33, 2009
  13. Sham JS, Chiu KW, Pang PK, Hypotensive action of Acacia catechu, Planta Med 50(2), 177-80, 1984.